Coya Therapeutics (COYA) Preferred Shares (2021 - 2022)
Coya Therapeutics (COYA) posted Preferred Shares of $8.8 million for Q4 2022, little changed sequentially from $8.8 million in Q4 2021, and little changed YoY from $8.8 million in Q4 2021.
Coya Therapeutics (COYA) Preferred Shares (2021 - 2022) Analysis & Trends
Coya Therapeutics has reported Preferred Shares for 2 years, with the latest figure at $8.8 million in Q4 2022.
- Quarterly Preferred Shares changed 0.0% year-over-year to $8.8 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $8.8 million (changed 0.0% YoY) and the FY2022 annual result came in at $8.8 million, changed 0.0% from the prior year.
- Preferred Shares steadied at $8.8 million in Q4 2022 per COYA's latest filing, from $8.8 million in the prior quarter.
- Over five years, Preferred Shares peaked at $8.8 million in Q4 2021 and troughed at $8.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Coya Therapeutics | 113.53 Mn | 70.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8.79 Mn |
| Dec 31, 2021 | 8.79 Mn |